Spectrum of Newly Diagnosed Cytomegalovirus Retinitis in a Developing Country in the HAART Era

References

• Jabs DA. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc. 1995;93:623–683.
   PubMedGoogle Scholar
• Peters BS, Beck EJ, Anderson S, et al. Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival. J Infect. 1991;23:129–137.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Jabs DA, Kempen JH, et al. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly Active antiretroviral therapy. Ophthalmology. 2006;113:1441–1445. doi:10.1016/j.ophtha.2006.03.022.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Bartlett JG. AIDS and ophthalmology: a period of transition. Am J Ophthalmol. 1997;124:227–233.
   PubMed Web of Science ®Google Scholar
• Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–860. doi:10.1056/NEJM199803263381301.
   PubMed Web of Science ®Google Scholar
• Ausayakhun S, Watananikorn S, Ittipunkul N, et al. Epidemiology of the ocular complications of HIV infection in Chiang Mai. J Med Assoc Thai. 2003;86:399–406.
   PubMedGoogle Scholar
• Heiden D, Ford N, Wilson D, et al. Cytomegalovirus retinitis: the neglected disease of global pandemic. Plos Med. 2007;4:e334. doi:10.1371/journal.pmed.0040334.
   PubMed Web of Science ®Google Scholar
• Biswas J, Madhavan HN, George AE, et al. Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated in a referral center. Am J Ophthalmol. 2000;129:9–15.
   PubMed Web of Science ®Google Scholar
• Shah SU, Kerkar SP, Pazare AR. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India. Br J Ophthalmol. 2009;93:88–90. doi:10.1136/bjo.2008.149237.
   PubMed Web of Science ®Google Scholar
• Pathai S, Gilbert C, Weiss HA, et al. Differing spectrum of HIV-associated ophthalmic disease among patients starting antiretroviral therapy in India and South Africa. Trop Med Int Health. 2011;16:356–359. doi:10.1111/j.1365-3156.2010.02712.x.
   PubMed Web of Science ®Google Scholar
• Gharai S, Venkattesh P, Garg S, et al. Ophthalmic mainifestations of HIV infection in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol. 2008;15:264–271. doi:10.1080/09286580802077716.
   PubMed Web of Science ®Google Scholar
• Sudharshan S, Kaleemunnisha S, Banu AA, et al. Ocular lesions in 1,000 consecutive HIV-positive patients in India: a long term study. J Oph Inflam Infec. 2013;3:2. doi:10.1186/1869-5760-3-2.
   PubMedGoogle Scholar
• Foscarnet- ganciclovir cytomegalovirus retinitis trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS research group in collaboration with the AIDS clinical trials group. Am J Ophthalmol. 1997;124:141–157.
   PubMedGoogle Scholar
• Holland GN, Vaudaux JD, Shiramizu KM, et al. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Am J Ophthalmol. 2008;145:12–22. doi:10.1016/j.ajo.2007.09.040.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Van Natta ML, Kempen JH, et al. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2002;133:48–61.
   PubMed Web of Science ®Google Scholar
• Ausayakhun S, Keenan JD, Ausayakhun S, et al. Clinical features of newly diagnosed cytomegalovirus retinitis in northern Thailand. Am J Ophthalmol. 2012;153:923–931. doi:10.1016/j.ajo.2011.10.012.
   PubMed Web of Science ®Google Scholar
• Bourne R, Price H, Taylor H, et al. New systematic review methodology for visual impairment and blindness for the 2010 global burden of disease study. Ophthalmic Epidemiol. 2013;20:33–39. doi:10.3109/09286586.2012.741279.
   PubMed Web of Science ®Google Scholar
• Holland GN, Buhles WC Jr, Mastre B, et al. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV retinopathy study group. Arch Ophthalmol. 1989;107(12):1759–1766. doi:10.1001/archopht.1989.01070020841024.
   PubMedGoogle Scholar
• Agarwal A, Singh R, Sharma A, et al. Ocular manifestations in patients with human immunodeficiency virus infection in the pre-HAART versus the HAART era in the north Indian population. Ocul Immunol Inflamm. 2017;25:396–404. doi:10.3109/09273948.2015.1133837.
   PubMed Web of Science ®Google Scholar
• Pertel P, Hirschtick R, Phair J, et al. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr. 1992;5:1069–1074.
   PubMed Web of Science ®Google Scholar
• Morjaria R, Sood V, Manavi K, et al. Lowering the limit: reducing the CD4 T-cell threshold for ophthalmic screening in patients with HIV in an ethnically diverse UK population. Clin Ophthalmol. 2014;8:2029–2034.
   PubMedGoogle Scholar
• Singh R, Bhalekar S, Parchand S, et al. Outcome of surgery in post-cytomegalovirus retinal detachment: experience before and in the era of highly active anti-retroviral therapy in Indian eyes. Indian J Ophthalmol. 2013;61:636–639. doi:10.4103/0301-4738.119426.
   PubMed Web of Science ®Google Scholar
• Murray HW, Know DL, Green WR, et al. Cytomegalovirus retinitis in adults. A manifestation of disseminated viral infection. Am J Med. 1977;63:574–584. doi:10.1016/0002-9343(77)90203-0.
   PubMed Web of Science ®Google Scholar
• Sommer A. Global access to eye care. Arch Ophthalmol. 2007;125:399–400. doi:10.1001/archopht.125.3.399.
   PubMedGoogle Scholar
• Holland GN. AIDS and ophthalmology: the first quarter century. Am J Ophthalmol. 2008;145:397–408. doi:10.1016/j.ajo.2007.12.001.
   PubMed Web of Science ®Google Scholar